TREATMENT OF PROSTHETIC TRICUSPID-VALVE THROMBOSIS WITH LOW-DOSE TISSUE PLASMINOGEN-ACTIVATOR

被引：14
|
作者：
COHEN, ML [1 ]
BARZILAI, B [1 ]
GUTIERREZ, F [1 ]
JAFFE, AS [1 ]
EISENBERG, P [1 ]
机构：
[1] WASHINGTON UNIV,SCH MED,EDWARD MALLINCKRODT INST RADIOL,ST LOUIS,MO 63110
来源：
AMERICAN HEART JOURNAL | 1990年 / 120卷 / 04期
关键词：
D O I：
10.1016/0002-8703(90)90220-R
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
[No abstract available]
引用
收藏
页码：978 / 980
页数：3
相关论文
共 50 条
  • [41] RECOMBINANT TISSUE-TYPE PLASMINOGEN-ACTIVATOR THERAPY IN PROSTHETIC MITRAL-VALVE THROMBOSIS - ASSESSMENT BY TRANSTHORACIC AND TRANSESOPHAGEAL ECHOCARDIOGRAPHY
    LOSI, MA
    BETOCCHI, S
    BRIGUORI, C
    MANGANELLI, F
    ELIA, PP
    SPAMPINATO, N
    CHIARIELLO, M
    INTERNATIONAL JOURNAL OF CARDIOLOGY, 1995, 48 (03) : 219 - 224
  • [42] WHAT IS THE OPTIMAL DOSE OF TISSUE PLASMINOGEN-ACTIVATOR
    KINNEY, EL
    WRIGHT, RJ
    CLINICAL RESEARCH, 1988, 36 (03): : A290 - A290
  • [43] The Successful Use of Low-Dose Recombinant Tissue Plasminogen Activator for Treatment of Intracardiac/Pulmonary Thrombosis During Liver Transplantation
    Boone, James D.
    Sherwani, Saadia S.
    Herborn, Joshua C.
    Patel, Kinjal M.
    De Wolf, Andre M.
    ANESTHESIA AND ANALGESIA, 2011, 112 (02): : 319 - 321
  • [44] EFFECTIVENESS OF PROLONGED LOW-DOSE RECOMBINANT TISSUE-TYPE PLASMINOGEN-ACTIVATOR FOR REFRACTORY UNSTABLE ANGINA
    ROMEO, F
    ROSANO, GMC
    MARTUSCELLI, E
    COMITO, M
    CARDONA, N
    COLISTRA, C
    MILANO, B
    BIANCO, C
    ROSANO, V
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 1995, 25 (06) : 1295 - 1299
  • [45] BOLUS DOSE-RESPONSE CHARACTERISTICS OF SINGLE CHAIN UROKINASE PLASMINOGEN-ACTIVATOR AND TISSUE PLASMINOGEN-ACTIVATOR IN A DOG-MODEL OF ARTERIAL THROMBOSIS
    BADYLAK, SF
    VOYTIK, S
    KLABUNDE, RE
    HENKIN, J
    LESKI, M
    THROMBOSIS RESEARCH, 1988, 52 (04) : 295 - 312
  • [46] COMPLETE PROSTHETIC VALVE THROMBOSIS DESPITE SEVERAL THROMBOLYTIC TREATMENTS AFTER TRICUSPID-VALVE REPLACEMENT
    COTTOGNI, M
    ANTRETTER, H
    FURTWANGLER, W
    THORACIC AND CARDIOVASCULAR SURGEON, 1993, 41 (03): : 199 - 201
  • [47] DEFICIENT TISSUE PLASMINOGEN-ACTIVATOR RELEASE AND NORMAL TISSUE PLASMINOGEN-ACTIVATOR INHIBITOR IN A PATIENT WITH RECURRENT DEEP-VEIN THROMBOSIS
    LATHAM, B
    KUFOY, EA
    BARRETT, O
    GONZALEZ, MF
    AMERICAN JOURNAL OF MEDICINE, 1990, 88 (02): : 199 - 200
  • [48] Low-Dose Tissue Plasminogen Activator and Standard-Dose Tissue Plasminogen Activator in Acute Ischemic Stroke in Asian Populations: A Review
    Ramaiah, Siva Seeta
    Yan, Bernard
    CEREBROVASCULAR DISEASES, 2013, 36 (03) : 161 - 166
  • [49] Management of prosthetic valve thrombosis with low dose, prolonged infusion of tissue type plasminogen activator under the guidance of serial transesophageal echocardiography during pregnancy
    Oguz, A. E.
    Duran, N. E.
    Yildiz, M.
    Biteker, M.
    Gunduz, S.
    Kaya, H.
    Aykan, A. C.
    Astarcioglu, M. A.
    Erturk, E.
    Ozkan, M.
    EUROPEAN HEART JOURNAL, 2009, 30 : 406 - 406
  • [50] LOCAL THROMBOLYSIS OF PERIPHERAL ARTERIAL OCCLUSIONS BY INFILTRATION TECHNIQUE USING LOW-DOSE RECOMBINANT TISSUE PLASMINOGEN-ACTIVATOR
    FISCHER, M
    BEER, D
    VONWRANGELL, U
    MEDIZINISCHE KLINIK, 1992, 87 (11) : 563 - 566
12345